Meet Our Team

Dianna Wheaton logo

Registry Director

Dianna K.H. Wheaton, MS, PhD, CHES

Dr. Wheaton joined the field of FTD research as Director of the FTD Disorders Registry in January 2016. She obtained her Master of Science degree in Biology (Genetic Counseling) from the University of North Texas and her Ph.D. in Health Studies (Community/Population Health) from the Texas Woman’s University. Dianna served as the first Director of the Southwest Eye Registry, guiding it from its early days to a registry that has supported a number of clinical trials. She has more than 20 years of clinical science research experience and genetic counseling for patients and at-risk family members.

As Registry Director, Dianna manages the daily operations of the FTD Disorders Registry, working directly with persons diagnosed with FTD and their families, and leading outreach efforts to the lay and health professional communities. She assists clinicians, other researchers, and organizations interested in using the Registry to answer important research questions and to support clinical trials. Dianna is the point of contact between potential users of the Registry and our Scientific Advisory Board of medical science experts who determine access to the data.



Sweatha Reddy

Sweatha Reddy joined the FTD Disorders Registry in January 2020 as Project Manager. She earned a B.S. in Biology from Creighton University and has more than five years of project management experience. She has worked within healthcare identifying gaps in clinical care, designing and executing research studies, and analyzing data to develop recommendations to improve patient outcomes. In addition, she has served as an advocate for the patient’s voice and experience to provide equitable and quality healthcare. 

As Project Manager, Sweatha serves as the liaison between the FTD Disorders Registry and the ALLFTD Study — a comprehensive study to better understand most varieties of frontotemporal lobar degeneration. In this role, she is able to combine her experience and passion for patient advocacy to help advance the science for FTD disorders.



Sherry Harlass

Sherry Harlass joined the FTD Disorders Registry team in January 2019 as Communications Coordinator. She obtained a B.A. in Journalism from Midwestern State University. After working for newspapers, magazines, and other print media, she migrated to the digital world 10 years ago and earned web design and social media marketing certificates from the University of Texas at Arlington. She has designed, built, and maintained websites as well as developed, implemented, and managed marketing campaigns. During the past 15 years, she has used her communications and project management skills primarily to serve nonprofits.

As Communications Manager, Sherry oversees the development and execution of the Registry’s print and digital content for both internal and external audiences. This includes branded marketing materials, informational handouts, graphics, emails, newsletters, and website content. She also creates, curates, and monitors posts on the Registry’s social channels: Facebook, Twitter, LinkedIn, and YouTube.


The Association for Frontotemporal Degeneration (AFTD)


AFTD Chief Executive Officer: Susan Dickinson, MSGC
As CEO of AFTD, Ms. Dickinson has ultimate responsibility for AFTD’s management of the Registry. Susan has led AFTD as CEO since 2008 and served on the Management Committee of the FTD Disorders Registry from its inception in 2016 to the management transition in 2020 with AFTD as the new managing member.

President & Secretary: Penny Dacks, PhD
As FTDDR President, Dr. Dacks oversees the FTD Disorders Registry and has responsibility for its sustainability and its external strategic relationships and partnerships. Penny also serves as AFTD’s Senior Director of Scientific Initiatives, where she leads strategy for AFTD’s research initiatives. She brings a decade of experience in biomedical nonprofit management, most recently as Associate Executive Director, Programs at the American Epilepsy Society, overseeing mission-related programs in research, medical education, and clinical activities. She trained in neuroscience at the University of Arizona and the Icahn School of Medicine at Mount Sinai.

Chief Financial Officer: Christine Stevens, MBA
As FTDDR CFO, Ms. Stevens is responsible for the design and oversight of appropriate financial controls, cash and investment management, engagement and management of auditors, and the annual audit and 990 preparation. In addition, she advises the Registry President and Director on issues such as employee benefits and HR policies, risk management, budgeting, vendor contracts, and financial compliance management. Christine has served as AFTD Chief Financial Officer since 2017. She holds an M.B.A. from Northeastern University and a B.A. in Economics from St. Lawrence University. She earned her CPA license working for PricewaterhouseCoopers.

Scientific Advisory Board of the FTD Disorders Registry

Our Advisory Board is composed of clinician and researcher volunteers from the FTD and dementia community. Each volunteer member is a recognized leader in the fields of FTD disorders, dementia, clinical care, patient registries, and clinical trials.

Dr. Adam Boxer, University of California, San Francisco, CA (Chair)

Dr. Boxer received his MD and PhD degrees at New York University Medical Center. He completed an internship in Internal Medicine at California Pacific Medical Center, a residency in Neurology at Stanford University Medical Center, and a fellowship in Behavioral Neurology at UCSF. He is an Associate Professor of Neurology and directs the Alzheimer’s Disease and Frontotemporal Dementia Clinical Trials Program at the Memory and Aging Center. Dr. Boxer, along with Dr. Brad Boeve (Mayo) and Dr. Howard Rosen (UCSF), is a lead investigator for the NIH-funded ALLFTD Study.

Dr. Brad Boeve, Mayo Clinic, Rochester, MN

Dr. Boeve received his MD degree at the University of Florida. He completed an internship in Internal Medicine, his residency in Neurology, and fellowships in Behavioral Neurology and Sleep Medicine at Mayo Clinic College of Medicine. He is a Professor and Chair of Behavioral Neurology at Mayo Clinic. Dr. Boeve, along with Dr. Adam Boxer (UCSF) and Dr. Howard Rosen (UCSF), is a lead investigator for the NIH-funded ALLFTD Study.

Dr. Lawrence I. Golbe, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ

Dr. Golbe received his MD degree at New York University School of Medicine. He completed his Internal Medicine residency at Hahnemann Hospital in Philadelphia before transferring into Neurology and completing his residency at NYU-Bellevue Hospital. Dr. Golbe is Professor Emeritus of Neurology at Rutgers Robert Wood Johnson Medical School and Director of the department’s Division of Movement Disorders.

Dr. David Knopman, Mayo Clinic, Rochester, MN

Dr. Knopman received his MD degree from the University of Minnesota, Twin Cities. He completed his internship at Hennepin County Medical Center, residency in Neurology at University of Minnesota Medical School, and fellowship in Aphasia and Behavioral Neurology at Hennepin County Medical Center. Dr. Knopman is Professor of Neurology at Mayo Clinic and served as the Chair of AFTD’s Medical Advisory Council.

Dr. Jessica Langbaum, Banner/API

Dr. Langbaum received her PhD in psychiatric epidemiology from Johns Hopkins University. She completed a post-doctoral research fellowship in brain imaging and Alzheimer’s disease at Banner Alzheimer’s Institute. She is a principal scientist at Banner Alzheimer’s Institute and the Associate Director of the Alzheimer’s Prevention Initiative (API).

Dr. Chiadi Onyike, Johns Hopkins Hospital, Baltimore, MD

Dr. Onyike received his MBBS (MD) degree from the University of Nigeria, College of Medicine. He completed a residency and fellowship in Psychiatry at Johns Hopkins University School of Medicine. He also obtained an MHS in Clinical Epidemiology from Johns Hopkins Bloomberg School of Public Health. He is an Associate Professor of Psychiatry and Behavioral Science at John Hopkins Hospital and Director of the Frontotemporal Dementia Program.